ATE241607T1 - Epoxybernsteinsäureamid-derivate - Google Patents

Epoxybernsteinsäureamid-derivate

Info

Publication number
ATE241607T1
ATE241607T1 AT98941728T AT98941728T ATE241607T1 AT E241607 T1 ATE241607 T1 AT E241607T1 AT 98941728 T AT98941728 T AT 98941728T AT 98941728 T AT98941728 T AT 98941728T AT E241607 T1 ATE241607 T1 AT E241607T1
Authority
AT
Austria
Prior art keywords
alkyl
heterocyclic
group
aryl
aralkyl
Prior art date
Application number
AT98941728T
Other languages
English (en)
Inventor
Yutaka Nomura
Toshihiro Takahashi
Yasushi Yoshino
Koichiro Nishioka
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Application granted granted Critical
Publication of ATE241607T1 publication Critical patent/ATE241607T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98941728T 1997-09-04 1998-09-04 Epoxybernsteinsäureamid-derivate ATE241607T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25753897 1997-09-04
PCT/JP1998/003983 WO1999011640A1 (en) 1997-09-04 1998-09-04 Epoxysuccinamide derivatives

Publications (1)

Publication Number Publication Date
ATE241607T1 true ATE241607T1 (de) 2003-06-15

Family

ID=17307684

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98941728T ATE241607T1 (de) 1997-09-04 1998-09-04 Epoxybernsteinsäureamid-derivate

Country Status (10)

Country Link
US (2) US6387908B1 (de)
EP (2) EP1022276B1 (de)
JP (1) JP4336039B2 (de)
AT (1) ATE241607T1 (de)
AU (1) AU8997898A (de)
DE (1) DE69815137T2 (de)
DK (1) DK1022276T3 (de)
ES (1) ES2201524T3 (de)
PT (1) PT1022276E (de)
WO (1) WO1999011640A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005515254A (ja) 2002-01-17 2005-05-26 スミスクライン ビーチャム コーポレーション カテプシンｋ阻害剤として有用なシクロアルキルケトアミド誘導体
US8013014B2 (en) * 2002-07-05 2011-09-06 Georgia Tech Research Corporation Aza-peptide epoxides
US7056947B2 (en) * 2002-07-05 2006-06-06 Georgia Tech Research Corp. Aza-peptide epoxides
JP4376184B2 (ja) * 2002-09-11 2009-12-02 日本ケミファ株式会社 アミン誘導体
EP1619190B1 (de) 2003-04-25 2010-12-29 Nippon Chemiphar Co., Ltd. Salze von (2s,3s)-3- [[(1s)-1-isobutoxymethyl-3-methylbutyl]carbamoyl] oxirane-2-carbonsäure
AU2005214388A1 (en) * 2004-02-18 2005-09-01 Georgia Tech Research Corporation Propenoyl hydrazides
DE602006020052D1 (de) 2005-09-28 2011-03-24 Robert Ternansky Neue arzneimittel gegen demenz
EP2019688A2 (de) * 2006-05-22 2009-02-04 Velcura Therapeutics, Inc. Verwendung von cathepsin-k-antagonisten bei der knochenherstellung
US20100216875A1 (en) * 2006-12-20 2010-08-26 Gregory Hook Methods of treating alzheimer's disease
US20110092484A1 (en) 2007-06-08 2011-04-21 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for cerebral aneurysm
JPWO2009054454A1 (ja) * 2007-10-24 2011-03-03 国立大学法人 東京医科歯科大学 カテプシン阻害剤を有効成分として含有するＴｏｌｌ様受容体のシグナル伝達の調整剤
WO2009065098A1 (en) * 2007-11-16 2009-05-22 Velcura Therapeutics, Inc. Use of cathepsin k antagonists in the treatment of bone cancer
JP2011241148A (ja) * 2008-09-08 2011-12-01 Nippon Chemiphar Co Ltd 医療用固形製剤
JP2012148978A (ja) * 2009-09-24 2012-08-09 Nippon Chemiphar Co Ltd 歯周病又は根尖性歯周炎の予防又は治療剤
KR20140034821A (ko) 2011-05-16 2014-03-20 바이엘 인텔렉쳐 프로퍼티 게엠베하 폐고혈압 및/또는 심부전의 치료 및/또는 예방을 위한 카텝신 k 억제의 용도
CA3145109A1 (en) * 2019-06-24 2020-12-30 Diverse Biotech, Inc. Cannabinoid conjugate molecules

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5934711B2 (ja) 1975-09-03 1984-08-24 大正製薬株式会社 エポキシコハク酸エステル類の製法
JPS6037104B2 (ja) * 1977-03-04 1985-08-24 大正製薬株式会社 エポキシコハク酸モノエステル誘導体
JPS6059232B2 (ja) * 1977-03-03 1985-12-24 大正製薬株式会社 エポキシサクシニルアミノ酸誘導体
JPS5535012A (en) * 1978-09-02 1980-03-11 Taisho Pharmaceut Co Ltd Compound of epoxysuccinylamino acid
JPS55115878A (en) * 1979-02-27 1980-09-06 Taisho Pharmaceut Co Ltd Epoxysuccinic acid derivative
JPS5772913A (en) * 1980-10-22 1982-05-07 Nippon Chemiphar Co Ltd Remedy for cardiac infraction
JPS57169478A (en) * 1981-04-10 1982-10-19 Nippon Chemiphar Co Ltd Piperazine derivative
JPS58126879A (ja) * 1982-01-25 1983-07-28 Nippon Chemiphar Co Ltd 光学活性なピペラジン誘導体ならびに心筋梗塞の予防および治療剤
JPS6155509A (ja) 1984-08-27 1986-03-20 Dowa:Kk 気化バ−ナにおける燃焼促進装置
EP0269311A3 (de) 1986-11-17 1990-06-06 Merck & Co. Inc. Methoden zur Behandlung von Knochenleiden mittels Verabreichung von Cystein-Proteinaseinhibitoren
JP2515114B2 (ja) * 1987-01-23 1996-07-10 日本ケミフア株式会社 血小板凝集抑制剤
JP2515119B2 (ja) * 1987-04-20 1996-07-10 日本ケミフア株式会社 ピペラジン誘導体を含有する活性酸素産生抑制ならびに活性酸素除去作用を有する医薬組成物
JP2536754B2 (ja) * 1987-05-08 1996-09-18 日本ケミファ株式会社 ピペラジン誘導体
JPH0832698B2 (ja) * 1987-05-08 1996-03-29 日本ケミファ株式会社 ピペラジン誘導体
JP2554497B2 (ja) * 1987-06-10 1996-11-13 日本ケミファ株式会社 エポキシコハク酸誘導体を含有する医薬組成物
JPH02218610A (ja) 1989-02-21 1990-08-31 Toyo Jozo Co Ltd 骨疾患の予防および治療剤
US5068354A (en) * 1989-05-18 1991-11-26 Taisho Pharmaceutical Co., Ltd. Epoxysuccinic acid derivatives
JPH02304075A (ja) * 1989-05-18 1990-12-17 Taisho Pharmaceut Co Ltd エポキシコハク酸誘導体
JP2808877B2 (ja) * 1990-09-29 1998-10-08 大正製薬株式会社 エポキシスクシナム酸誘導体およびその中間体
CA2101417A1 (en) * 1992-08-14 1994-02-15 Ken-Ichi Saito Prophylactic and therapeutic treatment of alzheimer's disease
JPH06239835A (ja) 1992-12-25 1994-08-30 Mitsubishi Kasei Corp アミノケトン誘導体
JPH06336428A (ja) * 1993-05-27 1994-12-06 Takeda Chem Ind Ltd 免疫抑制剤
JPH07115985A (ja) * 1993-10-26 1995-05-09 Asahi Chem Ind Co Ltd 生理活性物質ａｍ４２９９、それらの製法ならびに用途
JPH08104683A (ja) * 1993-10-29 1996-04-23 Takeda Chem Ind Ltd エポキシコハク酸誘導体
US5556853A (en) * 1993-10-29 1996-09-17 Takeda Chemical Industries, Ltd. Epoxysuccinic acid derivatives
JPH08104684A (ja) 1994-05-31 1996-04-23 Takeda Chem Ind Ltd エポキシコハク酸関連化合物
WO1995032954A1 (en) * 1994-05-31 1995-12-07 Takeda Chemical Industries, Ltd. Epoxysuccinic acid derivatives, their production and use
JPH0841043A (ja) 1994-07-29 1996-02-13 Taisho Pharmaceut Co Ltd エポキシコハク酸誘導体
JPH0873352A (ja) * 1994-09-06 1996-03-19 Taisho Pharmaceut Co Ltd 高血圧治療剤
JPH08325282A (ja) * 1995-03-31 1996-12-10 Nippon Chemiphar Co Ltd ビスホスホン酸誘導体
EP0826681B1 (de) 1995-03-31 2002-10-09 Nippon Chemiphar Co., Ltd. Derivate der epoxybernsteinsäure
CA2226740A1 (en) * 1995-07-13 1997-01-30 Mitsuyoshi Azuma Piperazine derivative and its uses
ES2190139T3 (es) * 1995-10-25 2003-07-16 Senju Pharma Co Inhibidor de la angiogenesis.
US5733911A (en) * 1996-01-26 1998-03-31 Hitachi Chemical Co., Ltd. Method for inducing death of neoplastic cells using piperazne derivatives
US6997899B2 (en) * 2002-12-17 2006-02-14 Boston Scientific Scimed, Inc, Rapid exchange dilation catheter for non-vascular applications

Also Published As

Publication number Publication date
ES2201524T3 (es) 2004-03-16
JP4336039B2 (ja) 2009-09-30
DE69815137D1 (de) 2003-07-03
PT1022276E (pt) 2003-10-31
DK1022276T3 (da) 2003-09-29
EP1342720A3 (de) 2004-02-11
DE69815137T2 (de) 2004-04-08
EP1022276A4 (de) 2001-12-12
EP1022276B1 (de) 2003-05-28
EP1342720A2 (de) 2003-09-10
EP1022276A1 (de) 2000-07-26
US6387908B1 (en) 2002-05-14
US6689785B2 (en) 2004-02-10
US20020091131A1 (en) 2002-07-11
AU8997898A (en) 1999-03-22
WO1999011640A1 (en) 1999-03-11

Similar Documents

Publication Publication Date Title
ATE241607T1 (de) Epoxybernsteinsäureamid-derivate
DE69604714D1 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
DK385387A (da) Amidderivater
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
DE69010232D1 (de) 2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
DE69228879D1 (de) Amidino-derivate und ihre verwendung als no-synthase inhibitoren
ES2141137T3 (es) Agentes terapeuticos para la enfermedad de parkinson.
HUP9802323A2 (hu) Pirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények
KR900012916A (ko) 치환된 피리미딘 유도체, 이의 제조방법 및 툴(tool)로서의 이의 용도
PL368409A1 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a? receptor and their use as medicaments
ATE71090T1 (de) Heterocyclische verbindungen und deren herstellung und verwendung.
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
DE69316067D1 (de) Arzneimittel zur Verwendung bei der Behandlung von Parkinsonismus
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
DE3884139D1 (de) L-Prolin-Derivate, deren Herstellung und deren biologische Anwendungen.
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
ES2088903T3 (es) Nuevos inhibidores de la s-adenosilmetionina descarboxilasa.
DE69022564D1 (de) Benzoxazin- und Benzothiazin-Derivate und Herbizide, welche diese enthalten.
ATE79618T1 (de) Thiadiazolguanidine.
ATE53839T1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE181331T1 (de) Salmycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1261958B (it) 2-(sostituite immino)-tiazolidine e procedimento per la loro preparazione e loro impiego quali antianginose e/o analgesiche
ATE116287T1 (de) N-oxyimidsäurederivate.
TH27321A (th) ไบรไคเนติกออก เซไดเอซอล

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1022276

Country of ref document: EP